The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.941%)
Open: 69.00
High: 70.00
Low: 69.00
Prev. Close: 69.00
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of ProtoCOL 3 Systems to Chinese SFDA

8 Feb 2013 07:00

RNS Number : 4207X
Scientific Digital Imaging Plc
08 February 2013
 



Scientific Digital Imaging plc

("SDI" or the "Company")

(AIM: SDI)

Chinese SFDA to Install 25 ProtoCOL 3 Systems from SDI

US $120,000 Order Shows Strength of SDI's Imaging Technology in Asian Market

 

Cambridge, UK: Scientific Digital Imaging (SDI), a leader in innovative digital imaging systems for life science, technology and astronomy applications, is pleased to announce that its Synbiosis Division has sold 25 ProtoCOL 3 automated colony counting and inhibition zone sizing systems, in one order worth US $120,000, to major government organisation, the Chinese State Food and Drug Administration (SFDA).

 

The SFDA (the Chinese equivalent of the EMEA and FDA) formulates policies and programmes for the administration of drugs, medical devices, health food and cosmetics. Microbiologists at the SFDA will be using the ProtoCOL 3 systems to help increase productivity of vaccine and antibiotic testing at their regional laboratories across China.

 

The order for 25 units of Synbiosis' ProtoCOL 3 systems came via Hua Yue Enterprise Holdings Ltd, one of SDI's expert Chinese distributors. This sale is the largest order for these colony counters in 2013 and closely follows another large installation of 27 ProtoCOL 3 systems in Asia in 2012. SDI has successfully sold into the Asian market for a number of years and the software for many of SDI's systems has been written in Chinese for over a decade, making it easier for Chinese life scientists to access and successfully use the technology.

 

Commenting on the news SDI's Chairman, Ken Ford, stated: "Selling the ProtoCOL 3 systems to the Chinese equivalent of the FDA is a coup. Our technology was in a rigorous tender process against systems from 10 other US, European and Chinese companies so to come out on top is a boost, not just for our Synbiosis Division, but also for other life science firms in Cambridge's innovation hub."

 

Mike Creedon, SDI's Chief Executive Officer, continued: "This purchase by such a prestigious government organisation is a great start to the year for SDI. With this being the second large order for ProtoCOL 3 systems in Asia in less than a year, it also shows that our strategy of moving into the untapped Asian market with our life science equipment portfolio is proving very fruitful."

-Ends-

 

 

FOR FURTHER INFORMATION

 

Scientific Digital Imaging plc 01223 727144

Ken Ford, Chairman

Mike Creedon, Chief Executive Officer

www.scientificdigitalimaging.com

 

finnCap 020 7220 0500

Ed Frisby/Rose Herbert - Corporate Finance

Simon Starr - Corporate Broking

 

 

Note to Editors

Scientific Digital Imaging Plc

 

Scientific Digital Imaging plc (SDI) is focused on the application of digital imaging technology to the needs of the scientific and technology community. Its principal subsidiary is Synoptics Limited, which designs and manufactures special-purpose instruments for use mainly in the life sciences, supplying customers in the academic, research and health sectors. In addition under the Atik brand SDI designs and manufactures high-sensitivity cameras for both astronomical and life science applications.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUBAVROOAURAR
Date   Source Headline
19th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
13th Jan 20215:20 pmRNSExercise of Options and Total Voting Rights
12th Jan 20217:23 amRNSProgressive publishes new research
5th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
10th Dec 202010:20 amRNSDirector Dealing
10th Dec 20207:00 amRNSInvestor Presentation
9th Dec 20207:00 amRNSInterim Results
7th Dec 202011:06 amRNSSecond Price Monitoring Extn
7th Dec 202011:01 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSAcquisition of Monmouth Scientific Limited & TVR
26th Nov 20204:50 pmRNSExercise of Options and Total Voting Rights
28th Oct 20202:23 pmRNSChange of Website
22nd Oct 20207:00 amRNSTrading Update
23rd Sep 20202:06 pmRNSSecond Price Monitoring Extn
23rd Sep 20202:00 pmRNSPrice Monitoring Extension
23rd Sep 202011:40 amRNSResult of AGM
23rd Sep 20207:00 amRNSAGM Trading Update & Investor Meet Company Q&A
3rd Sep 20204:24 pmRNSExercise of Options and Total Voting Rights
26th Aug 20204:49 pmRNSPosting of AR&A and Notice of AGM - Replacement
26th Aug 20204:11 pmRNSPosting of AR&A and Notice of AGM
17th Aug 20204:36 pmRNSPrice Monitoring Extension
21st Jul 20202:06 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202010:51 amRNSDirector Dealing
21st Jul 20207:01 amRNSInvestor Presentation
21st Jul 20207:00 amRNSFinal Results
9th Jul 20207:00 amRNSNotice of Results
26th May 20202:06 pmRNSSecond Price Monitoring Extn
26th May 20202:00 pmRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSTrading & COVID-19 Update
20th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 20203:10 pmRNSHolding(s) in Company
31st Jan 20201:19 pmRNSHolding(s) in Company
24th Jan 20203:29 pmRNSExercise of Options
27th Dec 20199:30 amRNSHolding(s) in Company
19th Dec 20191:14 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSInterim Results
2nd Dec 20197:00 amRNSAcquisition
31st Oct 20197:00 amRNSChange of Name
9th Oct 201910:43 amRNSExercise of Options
25th Sep 20194:55 pmRNSResult of AGM
25th Sep 20197:00 amRNSAGM Trading Update
20th Sep 20191:15 pmRNSDate of Annual General Meeting
3rd Sep 20195:46 pmRNSPosting of Annual Report and Notice of AGM
22nd Jul 20197:04 amRNSDirector/PDMR Shareholding
18th Jul 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSTrading Update
15th May 20197:00 amRNSTrading Update
9th May 20197:00 amRNSSDI to present at Mello 2019
5th Apr 201911:02 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.